Literature DB >> 29553085

Efficacy of Glutaraldehyde-Treated Leaflets for Mitral Valve Repair to Treat Active Infective Endocarditis: A Case Report.

Susumu Isoda1, Ichiya Yamazaki1, Yusuke Matsuki1, Hiroto Tomita1, Yoshimi Yano2, Toshikazu Gondo3, Munetaka Masuda4.   

Abstract

We report the use of glutaraldehyde (GA) in a case of valve repair for mitral valve prolapse associated with active infective endocarditis. GA scrubbed at the site of infection decontaminates and reinforces infected fragile tissue, avoids excessive debridement, and strengthens the edges of valve leaflets to facilitate suturing.

Entities:  

Keywords:  active infective endocarditis; glutaraldehyde; mitral valve; valve repair

Mesh：

Substances：

Year:  2018        PMID： 29553085      PMCID： PMC6923727          DOI： 10.5761/atcs.cr.17-00222

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN： 1341-1098            Impact factor:   1.520


  10 in total

1.  Mitral valve repair provides improved outcome over replacement in active infective endocarditis.

Authors:  Elfriede Ruttmann; Christina Legit; Gerhard Poelzl; Silvana Mueller; Orest Chevtchik; Marco Cottogni; Hanno Ulmer; Othmar Pachinger; Guenther Laufer; Ludwig C Mueller
Journal:  J Thorac Cardiovasc Surg       Date:  2005-09       Impact factor: 5.209

2.  A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium.

Authors:  Shigeyuki Ozaki; Isamu Kawase; Hiromasa Yamashita; Shin Uchida; Yukinari Nozawa; Mikio Takatoh; So Hagiwara
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-08       Impact factor: 5.209

3.  British Association of Dermatologists' guidelines for the management of cutaneous warts 2014.

Authors:  J C Sterling; S Gibbs; S S Haque Hussain; M F Mohd Mustapa; S E Handfield-Jones
Journal:  Br J Dermatol       Date:  2014-10-01       Impact factor: 9.302

Review 4.  Bioprosthetic heart valves of the future.

Authors:  Rizwan A Manji; Burcin Ekser; Alan H Menkis; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-01-21       Impact factor: 3.907

5.  Surgical treatment of active infective endocarditis: a continued challenge.

Authors:  Tirone E David; Gheorghe Gavra; Christopher M Feindel; Tommaso Regesta; Susan Armstrong; Manjula D Maganti
Journal:  J Thorac Cardiovasc Surg       Date:  2006-11-30       Impact factor: 5.209

Review 6.  Antimicrobial activity, uses and mechanism of action of glutaraldehyde.

Authors:  S P Gorman; E M Scott; A D Russell
Journal:  J Appl Bacteriol       Date:  1980-04

7.  In vitro study of the optimum volume ratio of activator to adhesive in gelatin-resorcin-formalin glue.

Authors:  Susumu Isoda; Tamizo Kimura; Yuji Mashiko; Shingo Nakamura; Tadaaki Maehara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-05-06

8.  Aortic root necrosis after surgical treatment using gelatin-resorcinol-formaldehyde (GRF) glue in patients with acute type A aortic dissection.

Authors:  Shinichi Suzuki; Kiyotaka Imoto; Keiji Uchida; Yoshinori Takanashi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 1.520

Review 9.  Surgical treatment of active infective mitral valve endocarditis.

Authors:  Hiroichiro Yamaguchi; Kiyoyuki Eishi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2007-06       Impact factor: 1.520

10.  Tensile strength of human pericardium treated with glutaraldehyde.

Authors:  Hiromasa Yamashita; Shigeyuki Ozaki; Kiyotaka Iwasaki; Isamu Kawase; Yukinari Nozawa; Mitsuo Umezu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2012-04-27       Impact factor: 1.520
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.